Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronie's Disease
Date:10/11/2010

XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism.  Auxilium has four projects in clinical development.  XIAFLEX is in phase III of development for the treatment of Peyronie's disease and is in phase II of development for treatment of Frozen Shoulder syndrome (Adhesive Capsulitis).  Auxilium's transmucosal film product candidate for the treatment of overactive bladder (AA4010) and its fentanyl pain product using its transmucosal delivery system are in phase I of development.  The Company is currently seeking a partner to further develop these product candidates.  Auxilium has rights to additional pain products and products for hormone replacement and urologic disease using its transmucosal film delivery system.  Auxilium also has options to all indications using XIAFLEX for non-topical formulations.  For additional information, visit http://www.auxilium.com.

AUXILIUM SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 This release contains "forward-looking-statements" within the meaning of The Private Securities Litigation Reform Act of 1995, including statements regarding the timing of completion of enrollment of patients in the phase III trial for XIAFLEX for the treatment of Peyronie's disease and the number of patients enrolled and sites used; the level of interest in XIAFLEX as a treatment for Peyronie's disease among the urology community and prospective patients; the scope, timing, methodology, endpoints, safety and execution of the global development plan and the phase III studies for XIAFLEX for the treatment of Peyronie's disease; the timing of release of results from the phase III trial for XIAFLEX for the treatment of Peyronie's disease; the interpretation of data from earlier ph
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
7. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
8. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
9. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
10. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
(Date:7/29/2015)... 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that its ... news segment in Australia .  The Dario ... regulatory and reimbursement approval in that country. ... living with diabetes. As a case in point, the news ... a 13 year old boy with Type 1 diabetes and ...
(Date:7/29/2015)... FRANCISCO, Calif. , July 29, 2015 ... antibody company focused on developing innovative therapies to benefit ... focus on oncology, announced today that it received a ... ("NASDAQ") notifying the company that it is now compliant ... on the NASDAQ Global Market and is no longer ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 2KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 3KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 4
... 12 A Kansas State University graduate student has ... , Sara Rosenkranz, doctoral student in human nutrition, ... of body fat and lower levels of physical activity had greater ... "Kids who are overweight and inactive are having -- ...
... LONDON, Dec. 11 On December 11, 2008, ... and Drug Administration (FDA) - including the Drug ... Advisory Committee, and the Pulmonary-Allergy Drugs Advisory Committee ... risks of asthma medications containing long-acting beta-agonists (LABAs). ...
Cached Medicine Technology:K-State Researcher Finds Correlation Between Childhood Obesity and Asthma 2K-State Researcher Finds Correlation Between Childhood Obesity and Asthma 3AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 2AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 3AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on SYMBICORT(R) 4
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business ... is directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same ... of the National academy of Sciences, and has given researchers inklings to explore Rsu1 ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering a nationally ... Kalamazoo Strength & Conditioning. , The name change coincides with the release of ... training center over the past three years,” according to Jack Kelly, the center’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year in ... in the list of the 50 fastest growing companies in Jacksonville. This annual list ... community. On July 16th, a team of Vast Bridges staffers were on hand to ...
(Date:7/29/2015)... NY (PRWEB) , ... July 29, 2015 , ... CanAm ... approved by USCIS over the past month! I-829 approvals have been granted to investors ... Los Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge ...
(Date:7/29/2015)... ... July 29, 2015 , ... A June 10, 2015 article from the News-Press, ... the importance of having regular skin cancer screenings from an early age. Skin cancer ... rays. When caught early, skin cancer is rarely fatal; however, if left alone for ...
Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Vast Bridges Continues Its Swift Growth 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3
... Tampa, FL (Feb. 27, 2008) -- The cancer-related protein Akt ... forms bundles of tangled nerve cell fibers in the brain ... researchers at the University of South Florida and the Mayo ... online Feb. 21 in the early edition of the Proceedings ...
... Inc. (Nasdaq: MAPP ) today announced financial results ... The net loss for the fourth quarter and ... million, respectively, compared with $8.5,million and $25.8 million during ... equivalents and short-term investments as of,December 31, 2007 of ...
... Feb. 28 Mansfield ISD,s Ben Barber,Career and Technology ... of,a new Student Minor Procedures Laboratory, funded with a ... will ensure health,occupation students at Ben Barber get a ... simulates scenarios students would face if employed in a,physician,s ...
... Taps International Icon for Global Marketing Campaign and Cause-Related ... ... THE REUTER,S WNS FEED AT 4:05 ... Amway Corporation announced today,that it has signed two-time FIFA Player of the ...
... 28 Ten prominent journalists from the United States ... fourth annual TempletonCambridge Journalism Fellowships in Science & Religion. ... fellowships include a program of research and scholarship at ... fellows were announced today by the New York office ...
... Project, (http://www.thehealingproject.org ) is launching today Voices Who ... with,life-threatening or chronic illnesses. This website is designed ... individuals with a forum,where they can meet online., ... online tool in our,arsenal of interpersonal communication and ...
Cached Medicine News:Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 7Health News:Ben Barber Career Tech Academy Leaps Forward With Help From Methodist Mansfield 2Health News:International Soccer Superstar Ronaldinho Signs With Nutrilite(TM) 2Health News:International Soccer Superstar Ronaldinho Signs With Nutrilite(TM) 3Health News:International Soccer Superstar Ronaldinho Signs With Nutrilite(TM) 4Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 2Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 4Health News:New Social Networking Website Connects Patients and Caregivers 2
Designed as an excellent form of primary suspension...
... T.E.O.™ was designed to meet the constant ... traveling kit provides all components necessary to ... Pair 1002-A4 Aluminum pre-contoured adjustable knee joints ... , 2 Unique adjustable thigh bands , ...
... controlled compression and cold, the Calf Cryo/Cuff ... designed cuff provides complete calf coverage for ... a single cuff, or with a cooler ... The Cooler is available separately and can ...
... designed to comfortably restrict motion of ... motion of the fingers and wrist. ... splint may be trimmed using cast ... gun. One cotton stockinet is included ...
Medicine Products: